AngioDynamics/ANGO

$6.26

0%
-
1D1W1MYTD1YMAX

About AngioDynamics

AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.

Ticker

ANGO

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

James Clemmer

Employees

815

Headquarters

Latham, United States

AngioDynamics Metrics

BasicAdvanced
$250.74M
Market cap
-
P/E ratio
-$4.78
EPS
0.64
Beta
-
Dividend rate
$250.74M
0.64173
$11.38
$5.26
527.31K
2.293
1.617
-44.34%
-62.42%
-54.02%
0.774
1.157
1.829
-3.19%
-405.61%
8.64%

What the Analysts think about AngioDynamics

Analyst Ratings

Majority rating from 4 analysts.
Buy

Price Targets

Average projection from 4 analysts.
115.65% upside
High $18.00
Low $10.00
$6.26
Current price
$13.50
Average price target

AngioDynamics Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-249.93% profit margin
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$75.1M
-4.94%
Net income
$-187.7M
547.24%
Profit margin
-249.93%
581.01%

AngioDynamics Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 18.3%
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$0.02
-$0.12
-$0.05
-$0.16
-
Expected
$0.02
-$0.13
-$0.08
-$0.14
-$0.16
Surprise
-11.11%
-7.69%
-33.33%
18.3%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for AngioDynamics stock?

AngioDynamics (ANGO) has a market cap of $250.74M as of April 23, 2024.

What is the P/E ratio for AngioDynamics stock?

The price to earnings (P/E) ratio for AngioDynamics (ANGO) stock is 0 as of April 23, 2024.

Does AngioDynamics stock pay dividends?

No, AngioDynamics (ANGO) stock does not pay dividends to its shareholders as of April 23, 2024.

When is the next AngioDynamics dividend payment date?

AngioDynamics (ANGO) stock does not pay dividends to its shareholders.

What is the beta indicator for AngioDynamics?

AngioDynamics (ANGO) has a beta rating of 0.64. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the AngioDynamics stock price target?

The target price for AngioDynamics (ANGO) stock is $13.5, which is 115.65% above the current price of $6.26. This is an average based on projections from 4 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell AngioDynamics stock

Buy or sell AngioDynamics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing